Additional Information

Description

Bicillin C-R 1.2 million units is an antibiotic combination containing penicillin G benzathine and penicillin G procaine. It is used for the treatment of various bacterial infections, particularly those caused by susceptible strains of streptococci, staphylococci, and certain types of pneumococci. Bicillin C-R is commonly used for the management of infections such as syphilis, upper respiratory infections, and certain types of skin infections.

The formulation contains two forms of penicillin, allowing for a combination of immediate and sustained release. Penicillin G benzathine provides a long-acting effect, while penicillin G procaine offers a quicker onset of action. This dual mechanism ensures effective treatment over an extended period, which is beneficial for managing infections requiring prolonged antibacterial activity.

Bicillin C-R 1.2 million units is typically administered by healthcare professionals in a clinical setting, where it is injected intramuscularly. It is essential that the injection is administered properly to avoid irritation or tissue damage. The dose and frequency of administration depend on the specific infection being treated and the patient's clinical condition.